Cargando…
Flow-mediated-paradoxical vasoconstriction is independently associated with asymptomatic myocardial ischemia and coronary artery disease in type 2 diabetic patients
BACKGROUND: To investigate whether flow-mediated dilation (FMD) impairment, which precedes overt atherosclerosis, is associated with silent myocardial ischemia (SMI) and asymptomatic coronary artery disease (CAD) in type 2 diabetes. METHODS: Forearm FMD was measured by ultrasonography in 25 healthy...
Autores principales: | Nguyen, Minh Tuan, Pham, Isabelle, Valensi, Paul, Rousseau, Hélène, Vicaut, Eric, Laguillier-Morizot, Christelle, Nitenberg, Alain, Cosson, Emmanuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901336/ https://www.ncbi.nlm.nih.gov/pubmed/24428877 http://dx.doi.org/10.1186/1475-2840-13-20 |
Ejemplares similares
-
Evidence for a Specific Diabetic Cardiomyopathy: An Observational Retrospective Echocardiographic Study in 656 Asymptomatic Type 2 Diabetic Patients
por: Pham, Isabelle, et al.
Publicado: (2015) -
Epicardial adipose tissue volume and myocardial ischemia in asymptomatic people living with diabetes: a cross-sectional study
por: Cosson, Emmanuel, et al.
Publicado: (2021) -
Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study
por: Valensi, Paul, et al.
Publicado: (2016) -
Cardiovascular Risk Prediction Is Improved by Adding Asymptomatic Coronary Status to Routine Risk Assessment in Type 2 Diabetic Patients
por: Cosson, Emmanuel, et al.
Publicado: (2011) -
Performance of the 2019 ESC/EASD guideline strategy for the screening of silent coronary artery disease in patients with diabetes
por: Valensi, Paul, et al.
Publicado: (2023)